...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
【24h】

A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.

机译:反向计划和前向计划的强度调制放射治疗鼻咽癌的治疗计划分析。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To compare dose-volume histograms of target volumes and organs at risk in 57 patients with nasopharyngeal carcinoma (NPC) with inverse- (IP) or forward-planned (FP) intensity-modulated radiation treatment (IMRT). METHODS AND MATERIALS: The DVHs of 57 patients with NPC with IMRT with or without chemotherapy were reviewed. Thirty-one patients underwent IP IMRT, and 26 patients underwent FP IMRT. Treatment goals were to prescribe a minimum dose of 66-70 Gy for gross tumor volume and 59.4 Gy for planning target volume to greater than 95% of the volume. Multiple selected end points were used to compare dose-volume histograms of the targets, including minimum, mean, and maximum doses; percentage of target volume receiving less than 90% (1-V90%), less than 95% (1-V95%), and greater than 105% (1-V105%). Dose-volume histograms of organs at risk were evaluated with characteristic end points. RESULTS: Both planning methods provided excellent target coverage with no statistically significant differences found, although a trend was suggested in favor of improved target coverage with IP IMRT in patients with T3/T4 NPC (p = 0.10). Overall, IP IMRT statistically decreased the dose to the parotid gland, temporomandibular joint, brain stem, and spinal cord overall, whereas IP led to a dose decrease to the middle/inner ear in only the T1/T2 subgroup. CONCLUSIONS: Use of IP and FP IMRT can lead to good target coverage while maintaining critical structures within tolerance. The IP IMRT selectively spared these critical organs to a greater degree and should be considered the standard of treatment in patients with NPC, particularly those with T3/T4. The FP IMRT is an effective second option in centers with limited IP IMRT capacity. As a modification of conformal techniques, the human/departmental resources to incorporate FP-IMRT should be nominal.
机译:目的:比较57例经鼻(IP)或正计划(FP)强度调制放射治疗(IMRT)的鼻咽癌(NPC)患者的目标体积和有风险器官的剂量体积直方图。方法和材料:回顾了57例IMRT伴或不伴化疗的NPC患者的DVHs。接受IP IMRT的患者31例,接受FP IMRT的患者26例。治疗目标是规定总肿瘤体积的最小剂量为66-70 Gy,计划目标体积的最小剂量为59.4 Gy,以大于体积的95%。使用多个选定的终点来比较目标的剂量-体积直方图,包括最小,平均和最大剂量;接收到的目标体积的百分比小于90%(1-V90%),小于95%(1-V95%)和大于105%(1-V105%)。用特征终点评估处于危险中的器官的剂量-体积直方图。结果:两种计划方法均提供了出色的靶标覆盖率,但未发现统计学上的显着差异,尽管有人建议采用IP IMRT改善T3 / T4 NPC患者的靶标覆盖率(p = 0.10)。总体而言,IP IMRT统计学上总体上减少了腮腺,颞下颌关节,脑干和脊髓的剂量,而IP仅在T1 / T2亚组中导致中耳/内耳的剂量减少。结论:IP和FP IMRT的使用可以导致良好的目标覆盖率,同时将关键结构保持在公差范围内。 IP IMRT在更大程度上有选择地避免了这些关键器官的出现,应将其视为NPC患者(尤其是T3 / T4患者)的治疗标准。在IP IMRT容量有限的中心,FP IMRT是有效的第二选择。作为对共形技术的修改,合并FP-IMRT的人力/部门资源应该是名义上的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号